The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Evan Adler
No Relationships to Disclose
 
Anwaruddin Mohammad
No Relationships to Disclose
 
Pankaj Kumar
No Relationships to Disclose
 
Robert Rounbehler
No Relationships to Disclose
 
Michelle Churchman
No Relationships to Disclose
 
Laura Graham
Honoraria - DAVA Oncology
Research Funding - Johnson & Johnson/Janssen (Inst); Merck (Inst); Pfizer (Inst)
 
Eric Singer
Consulting or Advisory Role - Aura Biosciences; Ferring
Research Funding - Astellas Medivation
 
Bodour Salhia
Leadership - CpG Diagnostics
Stock and Other Ownership Interests - CpG Diagnostics Inc
Consulting or Advisory Role - AstraZeneca
Patents, Royalties, Other Intellectual Property - Patents filed and pending at University of Southern California
Travel, Accommodations, Expenses - CpG Diagnostics In
 
Adanma Ayanambakkam
Consulting or Advisory Role - AVEO; Johnson and Johnson; Kura Oncology; Pfizer/Astellas
Research Funding - Regeneron
Travel, Accommodations, Expenses - Kura Oncology
 
Kenneth Nepple
Stock and Other Ownership Interests - Evidently
Consulting or Advisory Role - Evidently
Speakers' Bureau - Artera
 
Zin Myint
Research Funding - Merck (Inst)
 
Qiang Li
No Relationships to Disclose
 
Saum Ghodoussipour
Honoraria - Intuitive Surgical; Karl Storz; Urogen pharma
Speakers' Bureau - Natera; Urogen pharma
Research Funding - CG Oncology (Inst); Janssen (Inst)
 
Jennifer King
Research Funding - Exelixis
 
Daniel Grass
Employment - Moffitt Cancer Center
Stock and Other Ownership Interests - Editas Medicine; G1 Therapeutics; GlycoMimetics; Halozyme; Intellia Therapeutics; Lantheus Medical Imaging
Consulting or Advisory Role - MyCareGorithm
Research Funding - Artera
Patents, Royalties, Other Intellectual Property - MODELING VARIABILITY IN RADIOSENSITIVITY AND TUMOR IMMUNE CONTEXTURE TO PERSONALIZE RADIOTHERAPY
 
Sumati Gupta
Stock and Other Ownership Interests - Salarius Pharmaceuticals (I)
Research Funding - Acrotech Biopharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Daiichi Sankyo/Lilly (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Hoosier Cancer Research Network (Inst); Immunocore (Inst); Incyte (Inst); LSK BioPharma (Inst); MedImmune (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); QED Therapeutics (Inst); Rexahn Pharmaceuticals (Inst); Seagen (Inst); Viralytics (Inst)
(OPTIONAL) Uncompensated Relationships - Astellas Pharma
 
Paul Viscuse
Consulting or Advisory Role - Exelixis; Pfizer